keyword
https://read.qxmd.com/read/38636895/galectin-3-depletion-tames-pro-tumoural-microglia-and-restrains-cancer-cells-growth
#1
JOURNAL ARTICLE
Alberto Rivera-Ramos, Luis Cruz Hernández, Rocío Talaverón, María Teresa Sánchez Montero, Juan García-Revilla, Marta Mulero-Acevedo, Tomas Deierborg, José Luis Venero, Manuel Sarmiento Soto
Galectin-3 (Gal-3) is a multifunctional protein that plays a pivotal role in the initiation and progression of various central nervous system diseases, including cancer. Although the involvement of Gal-3 in tumour progression, resistance to treatment and immunosuppression has long been studied in different cancer types, mainly outside the central nervous system, its elevated expression in myeloid and glial cells underscores its profound impact on the brain's immune response. In this context, microglia and infiltrating macrophages, the predominant non-cancerous cells within the tumour microenvironment, play critical roles in establishing an immunosuppressive milieu in diverse brain tumours...
April 16, 2024: Cancer Letters
https://read.qxmd.com/read/38635031/vascular-mimicry-as-a-facilitator-of-melanoma-brain-metastasis
#2
JOURNAL ARTICLE
Olivia K Provance, Victor O Oria, Thuy T Tran, Jasmine I Caulfield, Christopher R Zito, Adam Aguirre-Ducler, Kurt A Schalper, Harriet M Kluger, Lucia B Jilaveanu
Melanoma has the highest propensity among solid tumors to metastasize to the brain. Melanoma brain metastases (MBM) are a leading cause of death in melanoma and affect 40-60% of patients with late-stage disease. Therefore, uncovering the molecular mechanisms behind MBM is necessary to enhance therapeutic interventions. Vascular mimicry (VM) is a form of neovascularization linked to invasion, increased risk of metastasis, and poor prognosis in many tumor types, but its significance in MBM remains poorly understood...
April 18, 2024: Cellular and Molecular Life Sciences: CMLS
https://read.qxmd.com/read/38629293/current-treatment-and-novel-insights-regarding-ros1-targeted-therapy-in-malignant-tumors
#3
REVIEW
Shizhe Li, He Zhang, Ting Chen, Xiaowen Zhang, Guanning Shang
BACKGROUND: The proto-oncogene ROS1 encodes an intrinsic type I membrane protein of the tyrosine kinase/insulin receptor family. ROS1 facilitates the progression of various malignancies via self-mutations or rearrangements. Studies on ROS1-directed tyrosine kinase inhibitors have been conducted, and some have been approved by the FDA for clinical use. However, the adverse effects and mechanisms of resistance associated with ROS1 inhibitors remain unknown. In addition, next-generation ROS1 inhibitors, which have the advantage of treating central nervous system metastases and alleviating endogenous drug resistance, are still in the clinical trial stage...
April 2024: Cancer Medicine
https://read.qxmd.com/read/38621710/large-skull-metastasis-in-follicular-thyroid-carcinoma-a-comprehensive-case-presentation-and-systematic-review
#4
JOURNAL ARTICLE
Gianluca Scalia, Massimiliano Porzio, Roberta Costanzo, Eliana Giurato, Fabio Gibilisco, Domenico Gerardo Iacopino, Rosario Maugeri, Giovanni Federico Nicoletti, Giuseppe Emmanuele Umana, Raffaele Alessandrello
BACKGROUND:  Skull metastases from follicular thyroid carcinoma (FTC) are infrequent but clinically significant, often presenting with localized pain, neurologic deficits, and cranial nerve dysfunction. Early detection and accurate diagnosis pose challenges due to their asymptomatic nature in some cases. METHODS:  A systematic literature review, conducted following the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) guidelines, identified and analyzed 15 relevant studies focusing on large skull metastases in FTC...
April 15, 2024: Journal of Neurological Surgery. Part A, Central European Neurosurgery
https://read.qxmd.com/read/38616506/integration-analysis-of-single-cell-transcriptome-reveals-specific-monocyte-subsets-associated-with-melanoma-brain-and-leptomeningeal-metastasis
#5
JOURNAL ARTICLE
Tao Liu, Jian-Ping Liu
BACKGROUND: Melanoma central nervous system (CNS) metastasis remains a leading cause of patient mortality, and the underlying pathological mechanism has not been fully elucidated, leading to a lack of effective therapeutic strategies. MATERIALS AND METHODS: In this study, we conducted an integrated analysis of single-cell transcriptomic data related to melanoma brain metastasis (MBM) and leptomeningeal metastasis (LMM). We focused on differences of subset composition and molecular expression of monocytes in blood, primary tumor, brain metastases, and leptomeningeal metastases...
April 2024: Skin Research and Technology
https://read.qxmd.com/read/38611589/evolution-of-a-meningothelial-meningioma-from-who-grade-1-to-anaplastic-grade-3-with-extracranial-metastasis-including-extensive-liver-metastasis
#6
JOURNAL ARTICLE
Christer Ruff, Paula Bombach, Georg Gohla, Till-Karsten Hauser, Frank Paulsen, Nick Farhang, Hans Boesmueller, Rudi Beschorner, Malte Bongers
A 61-year-old patient was diagnosed with a left-sided falx meningioma. Histopathological analysis following extirpation showed a meningothelial meningioma ZNS WHO grade 1 with sparse mitoses. Over the course of 12 years, the patient received irradiation (54.0 Gy), peptide radio-receptor therapy (177 Lu-DOMITATE) and targeted therapy (mTOR inhibitor). Follow-up imaging revealed an increased size of the residual tumor. Due to increased liver function parameters, imaging of the liver was performed, showing widespread space-occupying lesions with atypical appearance...
March 22, 2024: Diagnostics
https://read.qxmd.com/read/38611021/differential-competitive-growth-of-transgenic-subclones-of-neuroblastoma-cells-expressing-different-levels-of-cathepsin-d-co-cultured-in-2d-and-3d-in-response-to-egf-implications-in-tumor-heterogeneity-and-metastasis
#7
JOURNAL ARTICLE
Eleonora Secomandi, Andrea Esposito, Giulia Camurani, Chiara Vidoni, Amreen Salwa, Chiara Lualdi, Letizia Vallino, Alessandra Ferraresi, Ciro Isidoro
Neuroblastoma (NB) is an embryonal tumor arising from the sympathetic central nervous system. The epidermal growth factor (EGF) plays a role in NB growth and metastatic behavior. Recently, we have demonstrated that cathepsin D (CD) contrasts EGF-induced NB cell growth in 2D by downregulating EGFR/MAPK signaling. Aggressive NB is highly metastatic to the bone and the brain. In the metastatic process, adherent cells detach to form clusters of suspended cells that adhere once they reach the metastatic site and form secondary colonies...
March 29, 2024: Cancers
https://read.qxmd.com/read/38608213/systematic-review-of-cerebrospinal-fluid-biomarker-discovery-in-neuro-oncology-a-roadmap-to-standardization-and-clinical-application
#8
REVIEW
Nicholas Mikolajewicz, Patricia P Yee, Debarati Bhanja, Mara Trifoi, Alexandra M Miller, Philippe Metellus, Stephen J Bagley, Leonora Balaj, Leonardo J M de Macedo Filho, Brad E Zacharia, Dawit Aregawi, Michael Glantz, Michael Weller, Manmeet S Ahluwalia, Thomas Kislinger, Alireza Mansouri
Effective diagnosis, prognostication, and management of CNS malignancies traditionally involves invasive brain biopsies that pose significant risk to the patient. Sampling and molecular profiling of cerebrospinal fluid (CSF) is a safer, rapid, and noninvasive alternative that offers a snapshot of the intracranial milieu while overcoming the challenge of sampling error that plagues conventional brain biopsy. Although numerous biomarkers have been identified, translational challenges remain, and standardization of protocols is necessary...
April 12, 2024: Journal of Clinical Oncology
https://read.qxmd.com/read/38605228/lymphatic-vessels-in-the-age-of-cancer-immunotherapy
#9
REVIEW
Triantafyllia Karakousi, Tenny Mudianto, Amanda W Lund
Lymphatic transport maintains homeostatic health and is necessary for immune surveillance, and yet lymphatic growth is often associated with solid tumour development and dissemination. Although tumour-associated lymphatic remodelling and growth were initially presumed to simply expand a passive route for regional metastasis, emerging research puts lymphatic vessels and their active transport at the interface of metastasis, tumour-associated inflammation and systemic immune surveillance. Here, we discuss active mechanisms through which lymphatic vessels shape their transport function to influence peripheral tissue immunity and the current understanding of how tumour-associated lymphatic vessels may both augment and disrupt antitumour immune surveillance...
April 11, 2024: Nature Reviews. Cancer
https://read.qxmd.com/read/38584556/determination-of-pralsetinib-in-human-plasma-and-cerebrospinal-fluid-for-therapeutic-drug-monitoring-by-ultra-performance-liquid-chromatography-tandem-mass-spectrometry-uplc-ms-ms
#10
JOURNAL ARTICLE
Zichen Zhao, Qianlun Pu, Tonglin Sun, Qian Huang, Liping Tong, Ting Fan, Jingyue Kang, Yuhong Chen, Yan Zhang
BACKGROUND: Ultra-performance Liquid Chromatography-tandem Mass Spectrometry (UPLC-MS/MS) is widely used for concentration detection of many Tyrosine Kinase Inhibitors (TKIs), including afatinib, crizotinib, and osimertinib. In order to analyze whether pralsetinib takes effect in Rearranged during Transfection (RET)-positive patients with central nervous system metastasis, we aimed to develop a method for the detection of pralsetinib concentrations in human plasma and Cerebrospinal Fluid (CSF) by UPLC-MS/MS...
April 4, 2024: Anti-cancer Agents in Medicinal Chemistry
https://read.qxmd.com/read/38577848/a-case-report-of-prostate-cancer-with-leptomeningeal-metastasis-and-bone-marrow-involvement
#11
Maryam Garousi, Nima Mousavi Darzikolaee, Ali Faridfar, Seyed Mohammadreza Javadi, Esmaeil Samizadeh, Masoumeh Sajadi Rad, Reyhaneh Bayani
BACKGROUND: Prostate cancer is the second most common cancer in men. Central nervous system (CNS) involvement in prostate cancer which manifests as cerebral, leptomeningeal, or dural involvement is uncommon and occurs late in the course of disease. CASE: A 60-year-old patient with castration resistant prostate cancer (CRPC) presented with headache and fatigue. Evaluation revealed bone marrow and leptomeningeal involvement. The patient treated by whole brain radiotherapy, leuprolide, weekly docetaxel and daily 1000 mg abiraterone...
April 2024: Cancer reports
https://read.qxmd.com/read/38571468/tumefactive-primary-central-nervous-system-vasculitis-dynamic-susceptibility-contrast-perfusion-weighted-magnetic-resonance-imaging-findings-with-histological-correlation
#12
C F Muccio, L Di Lorenzo, G Lepore, F Savarese, S Schipani, I Chiarotti, A Cerase
PURPOSE: Primary central nervous system vasculitis (PCNSV) is a rare inflammatory disease affecting the central nervous system. In some cases, it presents with large, solitary lesion with extensive mass effect that mimic intracranial neoplasms. This condition results in a diagnostic confusion for neuroradiologists because the differentiation is almost impossible on conventional MRI sequences. The aim of this study is to reveal the significance of dynamic susceptibility contrast (DSC) perfusion-weighted imaging in differentiating of tumefactive PCNSV (t-PCNSV) lesions from intracranial neoplasms such as glio-blastomas and metastasis...
2024: La Clinica Terapeutica
https://read.qxmd.com/read/38563850/repurposing-mebendazole-against-triple-negative-breast-cancer-cns-metastasis
#13
JOURNAL ARTICLE
Adrian J Rodrigues, Sophia B Chernikova, Yuelong Wang, Thy T H Trinh, David E Solow-Cordero, Ludmila Alexandrova, Kerriann M Casey, Elizabeth Alli, Abhishek Aggarwal, Tyler Quill, Ashley K Koegel, Brian J Feldman, James M Ford, Melanie Hayden-Gephart
PURPOSE: Triple-negative breast cancer (TNBC) often metastasizes to the central nervous system (CNS) and has the highest propensity among breast cancer subtypes to develop leptomeningeal disease (LMD). LMD is a spread of cancer into leptomeningeal space that speeds up the disease progression and severely aggravates the prognosis. LMD has limited treatment options. We sought to test whether the common anti-helminthic drug mebendazole (MBZ) may be effective against murine TNBC LMD. METHODS: A small-molecule screen involving TNBC cell lines identified benzimidazoles as potential therapeutic agents for further study...
April 2, 2024: Journal of Neuro-oncology
https://read.qxmd.com/read/38558129/cancer-builds-a-noxious-partnership-with-psychologic-stress
#14
JOURNAL ARTICLE
Claire Magnon
I was recently surprised to hear a medical doctor on a TV show refute the role of stress in cancer, assuming that "the whole population would have cancer if this was the case." This statement illustrates a long and winding road since Hippocrates suggested the potential relationship between cancer and psychologic disturbances. The 20th and 21st centuries have finally witnessed the evidence of how physical or psychosocial stress situations contribute to the development and progression of cancer, and it is now assumed that psychologic stress does affect multiple aspects of cancer such as angiogenesis, immunologic escape, invasion, and metastasis...
April 1, 2024: Cancer Research
https://read.qxmd.com/read/38554330/a-comparative-study-of-whole-brain-radiotherapy-with-concomitant-thalidomide-versus-whole-brain-radiotherapy-alone-in-brain-metastases
#15
JOURNAL ARTICLE
Deiwakor Chyrmang, Yumkhaibam S Devi, Kishalay Baidya, Laishram J Singh, Daffilyne L Nongrum, Ningthoujam D Devi
BACKGROUND: Brain metastasis increases morbidity and mortality in cancer patients. This study was undertaken to compare tumor response and treatment-related toxicities in patients treated with orally administered thalidomide concomitantly with whole brain radiotherapy to whole brain radiotherapy alone in brain metastases. METHODS: This randomized control trial was conducted in radiation oncology department, RIMS among 42 patients of brain metastases distributed in two study arms during the period August 2018 to July 2020...
January 1, 2024: Journal of Cancer Research and Therapeutics
https://read.qxmd.com/read/38554307/clinical-diagnosis-and-management-of-multiple-cerebral-ring-enhancing-lesions-study-of-50-patients-at-a-tertiary-healthcare-center
#16
JOURNAL ARTICLE
Ankit Patel, Bhagirath More, Ishant Rege, Deepak Ranade
AIM OF THE STUDY: Multiple ring-enhancing lesions are commonly experienced group of brain pathologies which we come across in day-to-day practice. Clinical symptoms in these lesions are quite non-specific, and hence, it is difficult to reach a final diagnosis. However, these lesions have a varied group of differential diagnosis and it is sometimes difficult to have an accurate diagnosis on conventional MRI. This article was written with the objective of discussing the demographical study and etiology, clinical diagnosis and management for these patients...
January 1, 2024: Journal of Cancer Research and Therapeutics
https://read.qxmd.com/read/38553702/factors-associated-with-overall-survival-in-breast-cancer-patients-with-leptomeningeal-disease-lmd-a-single-institutional-retrospective-review
#17
JOURNAL ARTICLE
Gerald Wallace, Ronak Kundalia, Ethan Vallebuona, Biwei Cao, Youngchul Kim, Peter Forsyth, Aixa Soyano, Inna Smalley, Yolanda Pina
BACKGROUND: Breast cancer-related leptomeningeal disease (BC-LMD) is a dire diagnosis for 5-8% of patients with breast cancer (BC). We conducted a retrospective review of BC-LMD patients diagnosed at Moffitt Cancer Center from 2011 to 2020, to determine the changing incidence of BC-LMD, factors which are associated with the progression of BC CNS metastasis to BC-LMD, and factors which are associated with OS for patients with BC-LMD. METHODS: Patients with BC and brain/spinal metastatic disease were identified...
March 29, 2024: Breast Cancer Research: BCR
https://read.qxmd.com/read/38537208/68ga-fapi-pet-ct-in-an-interesting-case-of-metastatic-pulmonary-meningioma
#18
JOURNAL ARTICLE
Priyavrat Purohit, Bhagwant Rai Mittal, Rajender Kumar, Harmandeep Singh, Jaya Shukla, Amanjit Bal, Navneet Singh
Meningiomas are one of the major primary CNS tumors. Most meningiomas are benign, but rarely, these metastasize to distant organs, the lungs being the commonest site of metastasis. 18F-FDG PET/CT has been used to evaluate metastatic pulmonary meningioma. However, 68Ga-FAPI PET/CT has not yet been evaluated. The present case highlights the 68Ga-FAPI uptake in metastatic pulmonary meningioma in a postoperated case of left tentorial meningioma presenting with lung masses. Image-guided biopsy from the lung mass was consistent with metastatic meningioma...
March 25, 2024: Clinical Nuclear Medicine
https://read.qxmd.com/read/38534959/outcomes-of-patients-with-non-small-cell-lung-cancer-and-brain-metastases-treated-with-the-upfront-single-agent-pembrolizumab-a-retrospective-and-multicentric-study-of-the-esckeyp-gfpc-cohort
#19
MULTICENTER STUDY
Simon Nannini, Florian Guisier, Hubert Curcio, Charles Ricordel, Pierre Demontrond, Safa Abdallahoui, Seyyid Baloglu, Laurent Greillier, Christos Chouaid, Roland Schott
Non-small cell lung cancer (NSCLC) is the most common cause of brain metastasis (BM). Little is known about immune checkpoint inhibitor activity in the central nervous system, especially in patients receiving monotherapy for tumors with a tumor proportion score (TPS) ≥ 50%. This noninterventional, retrospective, multicenter study, conducted with the GFPC, included treatment-naïve patients strongly positive for PD-L1 (TPS ≥ 50%) with BM receiving first-line single-agent pembrolizumab treatment between May 2017 and November 2019...
March 21, 2024: Current Oncology
https://read.qxmd.com/read/38523251/nab2-stat6-fusions-and-genome-wide-dna-methylation-profiling-predictors-of-patient-outcomes-in-meningeal-solitary-fibrous-tumors
#20
JOURNAL ARTICLE
Kathryn L Eschbacher, Quynh T Tran, Evgeny A Moskalev, Sarah Jenkins, Karen Fritchie, Robert Stoehr, Alissa Caron, Michael J Link, Paul D Brown, Andrew Guajardo, Daniel J Brat, Ashley Wu, Sandro Santagata, David N Louis, Priscilla K Brastianos, Alexander B Kaplan, Brian Alexander, Sabrina Rossi, Fabio Ferrarese, David R Raleigh, Minh P Nguyen, John Gross, Jose Velazquez Vega, Fausto Rodriguez, Arie Perry, Maria Martinez-Lage, Brent A Orr, Florian Haller, Caterina Giannini
Meningeal solitary fibrous tumors (SFT) are rare and have a high frequency of local recurrence and distant metastasis. In a cohort of 126 patients (57 female, 69 male; mean age at surgery 53.0 years) with pathologically confirmed meningeal SFTs with extended clinical follow-up (median 9.9 years; range 15 days-43 years), we performed extensive molecular characterization including genome-wide DNA methylation profiling (n = 80) and targeted TERT promoter mutation testing (n = 98)...
March 24, 2024: Brain Pathology
keyword
keyword
90694
1
2
Fetch more papers »
Fetching more papers... Fetching...
Remove bar
Read by QxMD icon Read
×

Save your favorite articles in one place with a free QxMD account.

×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"

We want to hear from doctors like you!

Take a second to answer a survey question.